Grant: Discovery Grants Program - Individual
Simon Fraser University
$35,000.00
Molecular determinants of bHLH-PAS transcription factor function
FY 2010-11
Summary
The expression of genes in response to specific stimuli is carried out by a large group of proteins known as transcription factors. In order to direct transcription in an appropriate spatial and temporal fashion, these proteins must direct the coordinated assembly and disassembly of large protein machines on chromatin. The objective of my research program is to understand how proteins are shuttled to and from gene expression machinery during transcription by the basic-Helix-Loop-Helix-PAS (bHLH-PAS) family of transcription factors. It is my goal to understand how these changes alter protein function in response to different signals. This information will aid in the rational design of therapies that exploit transcription factor function and are directly targeted at their activities. I have chosen to study two tightly regulated model systems; aryl hydrocarbon receptor (AHR)-regulated CYP1A1 activity; and, hypoxia-inducible factor-1a (HIF-1a)-regulated VEGF and EPO expression. I have established that estrogens, through the estrogen receptor-alpha (ER), repress AHR function via direct protein-protein interactions. Furthermore, ER does so by facilitating an exchange for the histone deacetylase, HDAC4 for the co-repressor protein, RIP140 at the regulatory elements of AHR target genes. In part 1 of this study, I propose to elucidate the molecular determinants of ER-mediated repression of AHR-regulated transcription. I have designed a series of experiments to understand how estrogen-responsive recruitment of the repressor RIP140 modulates AHR activity and to determine the role HDAC4 plays in maintaining RIP140 in a state conducive to AHR-mediated gene transcription. The second part of this proposal outlines my plans to elucidate the role of the retinoblastoma protein (Rb) on HIF-1a regulated transcription. I have demonstrated that the co-activator TRIP230 is essential for transcriptional activation by HIF-1a. In addition, I have evidence that mediated HIF-1a-dependent transcriptional activity is negatively regulated by Rb. Together, these studies will increase our understanding of normal AHR physiology, vasculogenesis, and transcription factor function in general.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
356355-2008
Name nom
Beischlag, Timothy
Department département
Health Sciences, Faculty of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Partie
3
Nb partie
5
Application title
Molecular determinants of bHLH-PAS transcription factor function
Keyword
NSERC
Application summary
The expression of genes in response to specific stimuli is carried out by a large group of proteins known as transcription factors. In order to direct transcription in an appropriate spatial and temporal fashion, these proteins must direct the coordinated assembly and disassembly of large protein machines on chromatin. The objective of my research program is to understand how proteins are shuttled to and from gene expression machinery during transcription by the basic-Helix-Loop-Helix-PAS (bHLH-PAS) family of transcription factors. It is my goal to understand how these changes alter protein function in response to different signals. This information will aid in the rational design of therapies that exploit transcription factor function and are directly targeted at their activities. I have chosen to study two tightly regulated model systems; aryl hydrocarbon receptor (AHR)-regulated CYP1A1 activity; and, hypoxia-inducible factor-1a (HIF-1a)-regulated VEGF and EPO expression. I have established that estrogens, through the estrogen receptor-alpha (ER), repress AHR function via direct protein-protein interactions. Furthermore, ER does so by facilitating an exchange for the histone deacetylase, HDAC4 for the co-repressor protein, RIP140 at the regulatory elements of AHR target genes. In part 1 of this study, I propose to elucidate the molecular determinants of ER-mediated repression of AHR-regulated transcription. I have designed a series of experiments to understand how estrogen-responsive recruitment of the repressor RIP140 modulates AHR activity and to determine the role HDAC4 plays in maintaining RIP140 in a state conducive to AHR-mediated gene transcription. The second part of this proposal outlines my plans to elucidate the role of the retinoblastoma protein (Rb) on HIF-1a regulated transcription. I have demonstrated that the co-activator TRIP230 is essential for transcriptional activation by HIF-1a. In addition, I have evidence that mediated HIF-1a-dependent transcriptional activity is negatively regulated by Rb. Together, these studies will increase our understanding of normal AHR physiology, vasculogenesis, and transcription factor function in general.